https://www.avient.com/sites/default/files/2021-12/avient-espana-s.l.pdf
ÍNDICE DE EPÍGRAFES SOLICITADOS:
Datos Generales
Situaciones Especiales
DATOS GENERALES
Indice
AVIENT ESPAÑA SOCIEDAD LIMITADA
07/11/1983
Poligono Industrial, s/nºBARBASTRO22300-HUESCA
Indefinida
B22019723 EUID: ES22010.000000526
Hoja HU-2192 Tomo 494 Folio 6
La fabricacion y comercializacion de productos quimicos y auxiliares, tanto
naturales como sinteticos, en relacion con las industrias del caucho, de
resinas, de plasticos y de pinturas, y todas aquellas operaciones
mercantiles que se relacionen con dicho objeto.
https://www.avient.com/resource-center?document_type=59&document_subtype=216&page=0
White Paper
Learn more about this fiber dyeing technology, its advantages, and our color and additives portfolio to support it.
Sustainable Fiber Coloration Technology (Spin-Dyeing)
https://www.avient.com/resource-center?document_type=59&document_subtype=216
White Paper
Learn more about this fiber dyeing technology, its advantages, and our color and additives portfolio to support it.
Sustainable Fiber Coloration Technology (Spin-Dyeing)
https://www.avient.com/sites/default/files/2022-07/Mevopur Standard Colors Product Bulletin-CN.pdf
Mevopur Standard Colors Product Bulletin-CN3.26-1
MEVOPUR™ 着色剂
医疗应用的标准颜色
关键特性
监管支持
预先测试的原材料库,包括:
- ISO 10993
- USP , (class VI)
- USP
- ICHQ3D 可提取金属
- EuPh
向FDA提交的DMF / MAF文档适用于所有标
准颜色
医疗应用
医疗设备,例如导管,手术和牙科器械或药
物输送设备
药物包装,包括药瓶或瓶子
血液分析诊断或体外诊断(IVD)
产品公告 & 色卡
MEVOPUR 着色剂解决方案组合专为当今日益复
杂的医疗保健应用而设计。
https://www.avient.com/sites/default/files/2023-04/Rejoin PCR Colorant Product Bulletin_CN.pdf
Rejoin PCR Colorant MB Product Bulletin_CN4.12-3
用于聚烯烃的 Rejoin PCR着色剂™
*APR的2018年生命周期库存分析
产品公告
www.avient.com
版权所有©2023 埃万特公司。
https://www.avient.com/products/polymer-additives/surface-modifier-additives/cesa-anti-fog-additives
Color & Additives Animal Free & Food Contact Approved Film Additives
Superior Packaging Impact with Anti-Fog - White Paper
White Paper
https://www.avient.com/knowledge-base/article/new-aesthetix
Dark NIRvana – a range of dark, intense hues for high-end packaging in virgin and PCR HDPE, PP, PET, featuring NIR detectable colorants
Snow white and the seven speckles - discrete, white/off-white/pearlescent speckles for injection molded PE, PP, ABS, and SAN
https://www.avient.com/industries/healthcare/medical-devices-equipment/rehabilitation-equipment
Colorants for Disposable and Durable Nonwovens - Color Card
Color Card
Color Cosmetics
https://www.avient.com/sites/default/files/2023-11/AVNT Q3 2023 Earnings Press Release.pdf
You are advised to consult any further
disclosures we make on related subjects in our reports on Form 10-Q, 8-K and 10-K that we
provide to the Securities and Exchange Commission.
6
Investor Relations Contact:
Giuseppe (Joe) Di Salvo
Vice President, Treasurer and Investor Relations
Avient Corporation
+1 440-930-1921
giuseppe.disalvo@avient.com
Media Contact:
Kyle G.
2) Tax adjustments include the net tax impact from non-recurring income tax items, adjustments to uncertain tax position reserves and the
establishment, reversal or changes to valuation allowances.
10
Attachment 4
Avient Corporation
Condensed Consolidated Balance Sheets
(In millions)
(Unaudited)
September 30, 2023
December 31,
2022
ASSETS
Current assets:
Cash and cash equivalents $ 439.6 $ 641.1
Accounts receivable, net 436.9 440.6
Inventories, net 349.6 372.7
Other current assets 138.2 115.3
Total current assets 1,364.3 1,569.7
Property, net 978.2 1,049.2
Goodwill 1,681.3 1,671.9
Intangible assets, net 1,563.0 1,597.6
Other non-current assets 202.9 196.6
Total assets $ 5,789.7 $ 6,085.0
LIABILITIES AND SHAREHOLDERS' EQUITY
Current liabilities:
Short-term and current portion of long-term debt $ 9.5 $ 2.2
Accounts payable 389.5 454.4
Accrued expenses and other current liabilities 328.1 412.8
Total current liabilities 727.1 869.4
Non-current liabilities:
Long-term debt 2,070.8 2,176.7
Pension and other post-retirement benefits 65.1 67.2
Deferred income taxes 293.2 342.5
Other non-current liabilities 337.6 276.4
Total non-current liabilities 2,766.7 2,862.8
SHAREHOLDERS' EQUITY
Avient shareholders’ equity 2,276.9 2,334.5
Noncontrolling interest 19.0 18.3
Total equity 2,295.9 2,352.8
Total liabilities and equity $ 5,789.7 $ 6,085.0
11
Attachment 5
Avient Corporation
Condensed Consolidated Statements of Cash Flows (Unaudited)
(In millions)
Nine Months Ended
September 30,
2023 2022
Operating Activities
Net income $ 47.8 $ 158.5
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization 142.6 110.3
Accelerated depreciation 1.9 4.0
Share-based compensation expense 9.7 9.5
Changes in assets and liabilities, net of the effect of acquisitions:
Increase in accounts receivable (5.7) (66.5)
Decrease (increase) in inventories 16.5 (12.5)
(Decrease) increase in accounts payable (59.1) 43.5
Taxes paid on gain on sale of business (104.1) —
Accrued expenses and other assets and liabilities, net (2.5) (22.9)
Net cash provided by operating activities 47.1 223.9
Investing activities
Capital expenditures (75.0) (55.1)
Business acquisitions, net of cash acquired — (1,426.1)
Settlement of foreign exchange derivatives — 93.3
Net proceeds from divestiture 7.3 —
Other investing activities 2.3 —
Net cash used by investing activities (65.4) (1,387.9)
Financing activities
Debt proceeds — 1,300.0
Purchase of common shares for treasury — (36.4)
Cash dividends paid (67.6) (65.2)
Repayment of long-term debt (103.8) (6.8)
Debt financing costs (2.3) (49.3)
Other financing (2.3) (4.2)
Net cash (used) provided by financing activities (176.0) 1,138.1
Effect of exchange rate changes on cash (7.2) (30.9)
Decrease in cash and cash equivalents (201.5) (56.8)
Cash and cash equivalents at beginning of year 641.1 601.2
Cash and cash equivalents at end of period $ 439.6 $ 544.4
12
Attachment 6
Avient Corporation
Business Segment Operations (Unaudited)
(In millions)
Operating income and earnings before interest, taxes, depreciation and amortization (EBITDA) at the segment level does not
include: special items as defined in Attachment 3; corporate general and administration costs that are not allocated to segments;
intersegment sales and profit eliminations; share-based compensation costs; and certain other items that are not included in the
measure of segment profit and loss that is reported to and reviewed by the chief operating decision maker.
Three Months Ended
September 30,
Nine Months Ended
September 30,
2023 2022 2023 2022
Sales:
Color, Additives and Inks $ 486.5 $ 565.6 $ 1,548.0 $ 1,864.2
Specialty Engineered Materials 267.9 258.2 878.4 743.6
Corporate (0.7) (0.5) (2.6) (1.3)
Sales $ 753.7 $ 823.3 $ 2,423.8 $ 2,606.5
Gross margin:
Color, Additives and Inks $ 156.8 $ 161.3 $ 482.9 $ 546.8
Specialty Engineered Materials 78.3 66.9 263.7 201.3
Corporate (39.8) (32.8) (63.0) (37.4)
Gross margin $ 195.3 $ 195.4 $ 683.6 $ 710.7
Selling and administrative expense:
Color, Additives and Inks $ 92.3 $ 92.7 $ 284.8 $ 290.1
Specialty Engineered Materials 48.0 35.5 150.6 96.4
Corporate 20.7 26.6 94.5 81.3
Selling and administrative expense $ 161.0 $ 154.8 $ 529.9 $ 467.8
Operating income:
Color, Additives and Inks $ 64.5 $ 68.6 $ 198.1 $ 256.7
Specialty Engineered Materials 30.3 31.4 113.1 104.9
Corporate (60.5) (59.4) (157.5) (118.7)
Operating income $ 34.3 $ 40.6 $ 153.7 $ 242.9
Depreciation & amortization:
Color, Additives and Inks $ 24.6 $ 24.2 $ 76.1 $ 76.1
Specialty Engineered Materials 20.5 12.9 61.6 28.4
Corporate 1.3 2.7 6.8 9.2
Depreciation & Amortization $ 46.4 $ 39.8 $ 144.5 $ 113.7
Earnings before interest, taxes, depreciation and
amortization (EBITDA):
Color, Additives and Inks $ 89.1 $ 92.8 $ 274.2 $ 332.8
Specialty Engineered Materials 50.8 44.3 174.7 133.3
Corporate (59.2) (56.7) (150.7) (109.5)
Other income (expense), net 1.0 (32.3) 1.5 (31.3)
EBITDA including special items $ 81.7 $ 48.1 $ 299.7 $ 325.3
Special items in EBITDA 41.0 71.2 88.1 75.6
Total Company, EBITDA adjusted $ 122.7 $ 119.3 $ 387.8 $ 400.9
13
Attachment 7
Avient Corporation
Reconciliation of Non-GAAP Financial Measures (Unaudited)
(In millions, except per share data)
Senior management uses gross margin before special items and operating income before special items to assess performance
and allocate resources because senior management believes that these measures are useful in understanding current profitability
levels and how it may serve as a basis for future performance.
https://www.avient.com/sites/default/files/2023-07/AVNT Q2 2023 Earnings Press Release%5B43%5D.pdf
You are advised to consult any further
disclosures we make on related subjects in our reports on Form 10-Q, 8-K and 10-K that we
provide to the Securities and Exchange Commission.
6
Investor Relations Contact:
Giuseppe (Joe) Di Salvo
Vice President, Treasurer and Investor Relations
Avient Corporation
+1 440-930-1921
giuseppe.disalvo@avient.com
Media Contact:
Kyle G.
2) Tax adjustments include the net tax impact from non-recurring income tax items, adjustments to uncertain tax position reserves and the
establishment, reversal or changes to valuation allowances.
10
Attachment 4
Avient Corporation
Condensed Consolidated Balance Sheets
(In millions)
(Unaudited)
June 30, 2023
December 31,
2022
ASSETS
Current assets:
Cash and cash equivalents $ 528.7 $ 641.1
Accounts receivable, net 506.4 440.6
Inventories, net 359.0 372.7
Other current assets 116.6 115.3
Total current assets 1,510.7 1,569.7
Property, net 1,007.4 1,049.2
Goodwill 1,705.7 1,671.9
Intangible assets, net 1,614.7 1,597.6
Other non-current assets 213.3 196.6
Total assets $ 6,051.8 $ 6,085.0
LIABILITIES AND SHAREHOLDERS' EQUITY
Current liabilities:
Short-term debt $ 2.2 $ 2.2
Accounts payable 428.7 454.4
Accrued expenses and other current liabilities 345.6 412.8
Total current liabilities 776.5 869.4
Non-current liabilities:
Long-term debt 2,179.2 2,176.7
Pension and other post-retirement benefits 67.3 67.2
Deferred income taxes 304.8 342.5
Other non-current liabilities 370.3 276.4
Total non-current liabilities 2,921.6 2,862.8
SHAREHOLDERS' EQUITY
Avient shareholders’ equity 2,334.7 2,334.5
Noncontrolling interest 19.0 18.3
Total equity 2,353.7 2,352.8
Total liabilities and equity $ 6,051.8 $ 6,085.0
11
Attachment 5
Avient Corporation
Condensed Consolidated Statements of Cash Flows (Unaudited)
(In millions)
Six Months Ended
June 30,
2023 2022
Operating Activities
Net income $ 42.7 $ 169.2
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization 96.2 71.1
Accelerated depreciation 1.9 3.2
Share-based compensation expense 6.5 6.3
Changes in assets and liabilities, net of the effect of acquisitions:
Increase in accounts receivable (66.6) (133.2)
Decrease (increase) in inventories 14.0 (45.9)
(Decrease) increase in accounts payable (26.2) 98.5
Accrued expenses and other assets and liabilities, net (93.2) (62.5)
Net cash (used) provided by operating activities (24.7) 106.7
Investing activities
Capital expenditures (45.9) (34.0)
Settlement of foreign exchange derivatives — 75.1
Net proceeds from divestiture 7.3 —
Net cash used by investing activities (38.6) 41.1
Financing activities
Purchase of common shares for treasury — (36.4)
Cash dividends paid (45.0) (43.5)
Repayment of long-term debt (1.0) (4.4)
Other financing (2.3) (4.1)
Net cash used by financing activities (48.3) (88.4)
Effect of exchange rate changes on cash (0.8) (15.5)
Decrease in cash and cash equivalents (112.4) 43.9
Cash and cash equivalents at beginning of year 641.1 601.2
Cash and cash equivalents at end of period $ 528.7 $ 645.1
12
Attachment 6
Avient Corporation
Business Segment Operations (Unaudited)
(In millions)
Operating income and earnings before interest, taxes, depreciation and amortization (EBITDA) at the segment level does not
include: special items as defined in Attachment 3; corporate general and administration costs that are not allocated to segments;
intersegment sales and profit eliminations; share-based compensation costs; and certain other items that are not included in the
measure of segment profit and loss that is reported to and reviewed by the chief operating decision maker.
Three Months Ended
June 30,
Six Months Ended
June 30,
2023 2022 2023 2022
Sales:
Color, Additives and Inks $ 524.5 $ 649.1 $ 1,061.5 $ 1,298.6
Specialty Engineered Materials 300.8 242.3 610.5 485.4
Corporate (0.9) (0.4) (1.9) (0.8)
Sales $ 824.4 $ 891.0 $ 1,670.1 $ 1,783.2
Gross margin:
Color, Additives and Inks $ 164.1 $ 193.4 $ 326.1 $ 385.5
Specialty Engineered Materials 91.5 66.0 185.4 134.4
Corporate (14.9) 1.5 (23.2) (4.6)
Gross margin $ 240.7 $ 260.9 $ 488.3 $ 515.3
Selling and administrative expense:
Color, Additives and Inks $ 96.1 $ 99.8 $ 192.5 $ 197.4
Specialty Engineered Materials 51.8 30.8 102.6 60.9
Corporate 30.5 30.2 73.8 54.7
Selling and administrative expense $ 178.4 $ 160.8 $ 368.9 $ 313.0
Operating income:
Color, Additives and Inks $ 68.0 $ 93.6 $ 133.6 $ 188.1
Specialty Engineered Materials 39.7 35.2 82.8 73.5
Corporate (45.4) (28.7) (97.0) (59.3)
Operating income $ 62.3 $ 100.1 $ 119.4 $ 202.3
Depreciation & amortization:
Color, Additives and Inks $ 25.7 $ 25.8 $ 51.5 $ 51.9
Specialty Engineered Materials 19.9 7.6 41.1 15.5
Corporate 2.0 3.1 5.5 6.9
Depreciation & Amortization $ 47.6 $ 36.5 $ 98.1 $ 74.3
Earnings before interest, taxes, depreciation and
amortization (EBITDA):
Color, Additives and Inks $ 93.7 $ 119.4 $ 185.1 $ 240.0
Specialty Engineered Materials 59.6 42.8 123.9 89.0
Corporate (43.4) (25.6) (91.5) (52.4)
Other income (expense), net (0.2) 1.6 0.5 1.0
EBITDA including special items $ 109.7 $ 138.2 $ 218.0 $ 277.6
Total Company special items in EBITDA 21.6 (0.2) 47.1 4.4
Total Company, EBITDA adjusted $ 131.3 $ 138.0 $ 265.1 $ 282.0
13
Attachment 7
Avient Corporation
Reconciliation of Non-GAAP Financial Measures (Unaudited)
(In millions, except per share data)
Senior management uses gross margin before special items and operating income before special items to assess performance
and allocate resources because senior management believes that these measures are useful in understanding current profitability
levels and how it may serve as a basis for future performance.